A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. (Record no. 18151995)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02213 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515131620.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200809s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1078-0432 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-07-4123 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Flaherty, Keith T |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20080908 |
| 245 00 - TITLE STATEMENT | |
| Title | A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | Aug 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 4836-42 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzenesulfonates |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biopsy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carboplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Niacinamide |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenylurea Compounds |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyridines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sorafenib |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Time Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schiller, Joan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schuchter, Lynn M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Glenn |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tuveson, David A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Redlinger, Maryann |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lathia, Chetan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xia, Chenghua |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Petrenciuc, Oana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hingorani, Sunil R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jacobetz, Michael A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Van Belle, Patricia A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elder, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brose, Marcia S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weber, Barbara L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Albertini, Mark R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Dwyer, Peter J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 14 |
| -- | no. 15 |
| -- | p. 4836-42 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-07-4123">https://doi.org/10.1158/1078-0432.CCR-07-4123</a> |
| Public note | Available from publisher's website |
No items available.